Insumate® is a valuable and specific peptide extracted from bitter melon (Momordica charantia). After 10 years of development in partnership with the renowned medical universities, it was discovered that this patented peptide sequence (mcIRBP-19) can activate insulin receptor activity and directly influence blood glucose regulation. The exclusively patented extraction technology of Insumate® complies with the highest industry standards. All production facilities have good sanitation certifications including HACCP, ISO22000, FSSC22000; no toxic solvents are used in the production process.